NCT00565851 · FLOW
Participant flow
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- groups
- description
- Patients receive paclitaxel IV over 3 hours or docetaxel IV over 1 hour and carboplatin over 30 minutes on day 1. Treatment repeats every 21 days. Patients are not in secondary cytoreductive surgery portion of study.
- id
- FG000
- title
- Arm I (no Surgery; Carboplatin and Paclitaxel)
- description
- Patients receive chemotherapy as in arm I and bevacizumab IV over 30-90 minutes on day 1. Treatment repeats every 21 days. Patients are not in secondary cytoreductive surgery portion of study.
- id
- FG001
- title
- Arm II (no Surgery; Carboplatin, Paclitaxel and Bevacizumab)
- description
- Patients receive paclitaxel IV over 3 hours or docetaxel IV over 1 hour and carboplatin over 30 minutes on day 1. Treatment repeats every 21 days. Patients receive secondary cytoreductive surgery.
- id
- FG002
- title
- Arm III (Surgery; Carboplatin and Paclitaxel)
- description
- Patients receive paclitaxel IV over 3 hours or docetaxel IV over 1 hour and carboplatin over 30 minutes on day 1. Treatment repeats every 21 days. Patients receive secondary cytoreductive surgery.
- id
- FG003
- title
- Arm IV (Surgery; Carboplatin, Paclitaxel and Bevacizumab)
- description
- Patients receive carboplatin as in arm I. Patients receive gemcitabine. Treatment repeats every 21 days. Patients do not receive secondary cytoreductive surgery.
- id
- FG004
- title
- Arm V (no Surgery; Carboplatin and Gemcitabine)
- description
- Patients receive carboplatin as in arm I and bevacizumab IV over 30-90 minutes on day 1. Patients receive gemcitabine. Treatment repeats every 21 days. Patients do not receive secondary cytoreductive surgery.
- id
- FG005
- title
- Arm VI (no Surgery; Carboplatin, Gemcitabine and Bevacizumab)
- description
- Patients receive carboplatin as in arm I. Patients receive gemcitabine. Treatment repeats every 21 days. Patients receive secondary cytoreductive surgery.
- id
- FG006
- title
- Arm VII (Surgery; Carboplatin and Gemcitabine)
- description
- Patients receive carboplatin as in arm I and bevacizumab IV over 30-90 minutes on day 1. Patients receive gemcitabine. Treatment repeats every 21 days. Patients receive secondary cytoreductive surgery.
- id
- FG007
- title
- Arm VIII (Surgery; Carboplatin, Gemcitabine and Bevacizumab)
- periods
- milestones
- achievements
- group Id
- FG000
- num Subjects
- 316
- group Id
- FG001
- num Subjects
- 456
- group Id
- FG002
- num Subjects
- 33
- group Id
- FG003
- num Subjects
- 165
- group Id
- FG004
- num Subjects
- 6
- group Id
- FG005
- num Subjects
- 34
- group Id
- FG006
- num Subjects
- 5
- group Id
- FG007
- num Subjects
- 37
- type
- STARTED
- achievements
- group Id
- FG000
- num Subjects
- 0
- group Id
- FG001
- num Subjects
- 0
- group Id
- FG002
- num Subjects
- 33
- group Id
- FG003
- num Subjects
- 165
- group Id
- FG004
- num Subjects
- 0
- group Id
- FG005
- num Subjects
- 0
- group Id
- FG006
- num Subjects
- 5
- group Id
- FG007
- num Subjects
- 37
- type
- Randomized - Yes Surgery
- achievements
- group Id
- FG000
- num Subjects
- 33
- group Id
- FG001
- num Subjects
- 172
- group Id
- FG002
- num Subjects
- 0
- group Id
- FG003
- num Subjects
- 0
- group Id
- FG004
- num Subjects
- 6
- group Id
- FG005
- num Subjects
- 34
- group Id
- FG006
- num Subjects
- 0
- group Id
- FG007
- num Subjects
- 0
- type
- Randomized - no Surgery
- achievements
- group Id
- FG000
- num Subjects
- 283
- group Id
- FG001
- num Subjects
- 284
- group Id
- FG002
- num Subjects
- 0
- group Id
- FG003
- num Subjects
- 0
- group Id
- FG004
- num Subjects
- 0
- group Id
- FG005
- num Subjects
- 0
- group Id
- FG006
- num Subjects
- 0
- group Id
- FG007
- num Subjects
- 0
- type
- Not Surgical Candidate
- achievements
- group Id
- FG000
- num Subjects
- 313
- group Id
- FG001
- num Subjects
- 454
- group Id
- FG002
- num Subjects
- 31
- group Id
- FG003
- num Subjects
- 154
- group Id
- FG004
- num Subjects
- 6
- group Id
- FG005
- num Subjects
- 34
- group Id
- FG006
- num Subjects
- 5
- group Id
- FG007
- num Subjects
- 35
- comment
- Includes participants who followed through with surgical assignment
- type
- COMPLETED
- achievements
- group Id
- FG000
- num Subjects
- 3
- group Id
- FG001
- num Subjects
- 2
- group Id
- FG002
- num Subjects
- 2
- group Id
- FG003
- num Subjects
- 11
- group Id
- FG004
- num Subjects
- 0
- group Id
- FG005
- num Subjects
- 0
- group Id
- FG006
- num Subjects
- 0
- group Id
- FG007
- num Subjects
- 2
- type
- NOT COMPLETED
- title
- Surgical Assignment
- drop Withdraws
- reasons
- group Id
- FG000
- num Subjects
- 9
- group Id
- FG001
- num Subjects
- 9
- group Id
- FG002
- num Subjects
- 3
- group Id
- FG003
- num Subjects
- 18
- group Id
- FG004
- num Subjects
- 0
- group Id
- FG005
- num Subjects
- 2
- group Id
- FG006
- num Subjects
- 0
- group Id
- FG007
- num Subjects
- 2
- type
- Never Initiated Chemotherapy
- reasons
- group Id
- FG000
- num Subjects
- 0
- group Id
- FG001
- num Subjects
- 14
- group Id
- FG002
- num Subjects
- 0
- group Id
- FG003
- num Subjects
- 18
- group Id
- FG004
- num Subjects
- 0
- group Id
- FG005
- num Subjects
- 1
- group Id
- FG006
- num Subjects
- 0
- group Id
- FG007
- num Subjects
- 1
- type
- Still On Chemotherapy
- milestones
- achievements
- group Id
- FG000
- num Subjects
- 316
- group Id
- FG001
- num Subjects
- 456
- group Id
- FG002
- num Subjects
- 33
- group Id
- FG003
- num Subjects
- 165
- group Id
- FG004
- num Subjects
- 6
- group Id
- FG005
- num Subjects
- 34
- group Id
- FG006
- num Subjects
- 5
- group Id
- FG007
- num Subjects
- 37
- type
- STARTED
- achievements
- group Id
- FG000
- num Subjects
- 310
- group Id
- FG001
- num Subjects
- 311
- group Id
- FG002
- num Subjects
- 27
- group Id
- FG003
- num Subjects
- 26
- group Id
- FG004
- num Subjects
- 0
- group Id
- FG005
- num Subjects
- 0
- group Id
- FG006
- num Subjects
- 0
- group Id
- FG007
- num Subjects
- 0
- type
- Randomized to Chemo
- achievements
- group Id
- FG000
- num Subjects
- 6
- group Id
- FG001
- num Subjects
- 145
- group Id
- FG002
- num Subjects
- 6
- group Id
- FG003
- num Subjects
- 139
- group Id
- FG004
- num Subjects
- 6
- group Id
- FG005
- num Subjects
- 34
- group Id
- FG006
- num Subjects
- 5
- group Id
- FG007
- num Subjects
- 37
- type
- Pre-specified Chemo
- achievements
- group Id
- FG000
- num Subjects
- 307
- group Id
- FG001
- num Subjects
- 433
- group Id
- FG002
- num Subjects
- 30
- group Id
- FG003
- num Subjects
- 129
- group Id
- FG004
- num Subjects
- 6
- group Id
- FG005
- num Subjects
- 31
- group Id
- FG006
- num Subjects
- 5
- group Id
- FG007
- num Subjects
- 34
- type
- COMPLETED
- achievements
- group Id
- FG000
- num Subjects
- 9
- group Id
- FG001
- num Subjects
- 23
- group Id
- FG002
- num Subjects
- 3
- group Id
- FG003
- num Subjects
- 36
- group Id
- FG004
- num Subjects
- 0
- group Id
- FG005
- num Subjects
- 3
- group Id
- FG006
- num Subjects
- 0
- group Id
- FG007
- num Subjects
- 3
- type
- NOT COMPLETED
- title
- Chemotherapy Assignment
- recruitment Details
- At the beginning of the study participants could be randomized to chemotherapy. On August 29, 2011 randomization to chemotherapy ended and participants could only be randomized to surgery.
Complete source fields
- groups
- description
- Patients receive paclitaxel IV over 3 hours or docetaxel IV over 1 hour and carboplatin over 30 minutes on day 1. Treatment repeats every 21 days. Patients are not in secondary cytoreductive surgery portion of study.
- id
- FG000
- title
- Arm I (no Surgery; Carboplatin and Paclitaxel)
- description
- Patients receive chemotherapy as in arm I and bevacizumab IV over 30-90 minutes on day 1. Treatment repeats every 21 days. Patients are not in secondary cytoreductive surgery portion of study.
- id
- FG001
- title
- Arm II (no Surgery; Carboplatin, Paclitaxel and Bevacizumab)
- description
- Patients receive paclitaxel IV over 3 hours or docetaxel IV over 1 hour and carboplatin over 30 minutes on day 1. Treatment repeats every 21 days. Patients receive secondary cytoreductive surgery.
- id
- FG002
- title
- Arm III (Surgery; Carboplatin and Paclitaxel)
- description
- Patients receive paclitaxel IV over 3 hours or docetaxel IV over 1 hour and carboplatin over 30 minutes on day 1. Treatment repeats every 21 days. Patients receive secondary cytoreductive surgery.
- id
- FG003
- title
- Arm IV (Surgery; Carboplatin, Paclitaxel and Bevacizumab)
- description
- Patients receive carboplatin as in arm I. Patients receive gemcitabine. Treatment repeats every 21 days. Patients do not receive secondary cytoreductive surgery.
- id
- FG004
- title
- Arm V (no Surgery; Carboplatin and Gemcitabine)
- description
- Patients receive carboplatin as in arm I and bevacizumab IV over 30-90 minutes on day 1. Patients receive gemcitabine. Treatment repeats every 21 days. Patients do not receive secondary cytoreductive surgery.
- id
- FG005
- title
- Arm VI (no Surgery; Carboplatin, Gemcitabine and Bevacizumab)
- description
- Patients receive carboplatin as in arm I. Patients receive gemcitabine. Treatment repeats every 21 days. Patients receive secondary cytoreductive surgery.
- id
- FG006
- title
- Arm VII (Surgery; Carboplatin and Gemcitabine)
- description
- Patients receive carboplatin as in arm I and bevacizumab IV over 30-90 minutes on day 1. Patients receive gemcitabine. Treatment repeats every 21 days. Patients receive secondary cytoreductive surgery.
- id
- FG007
- title
- Arm VIII (Surgery; Carboplatin, Gemcitabine and Bevacizumab)
- periods
- milestones
- achievements
- group Id
- FG000
- num Subjects
- 316
- group Id
- FG001
- num Subjects
- 456
- group Id
- FG002
- num Subjects
- 33
- group Id
- FG003
- num Subjects
- 165
- group Id
- FG004
- num Subjects
- 6
- group Id
- FG005
- num Subjects
- 34
- group Id
- FG006
- num Subjects
- 5
- group Id
- FG007
- num Subjects
- 37
- type
- STARTED
- achievements
- group Id
- FG000
- num Subjects
- 0
- group Id
- FG001
- num Subjects
- 0
- group Id
- FG002
- num Subjects
- 33
- group Id
- FG003
- num Subjects
- 165
- group Id
- FG004
- num Subjects
- 0
- group Id
- FG005
- num Subjects
- 0
- group Id
- FG006
- num Subjects
- 5
- group Id
- FG007
- num Subjects
- 37
- type
- Randomized - Yes Surgery
- achievements
- group Id
- FG000
- num Subjects
- 33
- group Id
- FG001
- num Subjects
- 172
- group Id
- FG002
- num Subjects
- 0
- group Id
- FG003
- num Subjects
- 0
- group Id
- FG004
- num Subjects
- 6
- group Id
- FG005
- num Subjects
- 34
- group Id
- FG006
- num Subjects
- 0
- group Id
- FG007
- num Subjects
- 0
- type
- Randomized - no Surgery
- achievements
- group Id
- FG000
- num Subjects
- 283
- group Id
- FG001
- num Subjects
- 284
- group Id
- FG002
- num Subjects
- 0
- group Id
- FG003
- num Subjects
- 0
- group Id
- FG004
- num Subjects
- 0
- group Id
- FG005
- num Subjects
- 0
- group Id
- FG006
- num Subjects
- 0
- group Id
- FG007
- num Subjects
- 0
- type
- Not Surgical Candidate
- achievements
- group Id
- FG000
- num Subjects
- 313
- group Id
- FG001
- num Subjects
- 454
- group Id
- FG002
- num Subjects
- 31
- group Id
- FG003
- num Subjects
- 154
- group Id
- FG004
- num Subjects
- 6
- group Id
- FG005
- num Subjects
- 34
- group Id
- FG006
- num Subjects
- 5
- group Id
- FG007
- num Subjects
- 35
- comment
- Includes participants who followed through with surgical assignment
- type
- COMPLETED
- achievements
- group Id
- FG000
- num Subjects
- 3
- group Id
- FG001
- num Subjects
- 2
- group Id
- FG002
- num Subjects
- 2
- group Id
- FG003
- num Subjects
- 11
- group Id
- FG004
- num Subjects
- 0
- group Id
- FG005
- num Subjects
- 0
- group Id
- FG006
- num Subjects
- 0
- group Id
- FG007
- num Subjects
- 2
- type
- NOT COMPLETED
- title
- Surgical Assignment
- drop Withdraws
- reasons
- group Id
- FG000
- num Subjects
- 9
- group Id
- FG001
- num Subjects
- 9
- group Id
- FG002
- num Subjects
- 3
- group Id
- FG003
- num Subjects
- 18
- group Id
- FG004
- num Subjects
- 0
- group Id
- FG005
- num Subjects
- 2
- group Id
- FG006
- num Subjects
- 0
- group Id
- FG007
- num Subjects
- 2
- type
- Never Initiated Chemotherapy
- reasons
- group Id
- FG000
- num Subjects
- 0
- group Id
- FG001
- num Subjects
- 14
- group Id
- FG002
- num Subjects
- 0
- group Id
- FG003
- num Subjects
- 18
- group Id
- FG004
- num Subjects
- 0
- group Id
- FG005
- num Subjects
- 1
- group Id
- FG006
- num Subjects
- 0
- group Id
- FG007
- num Subjects
- 1
- type
- Still On Chemotherapy
- milestones
- achievements
- group Id
- FG000
- num Subjects
- 316
- group Id
- FG001
- num Subjects
- 456
- group Id
- FG002
- num Subjects
- 33
- group Id
- FG003
- num Subjects
- 165
- group Id
- FG004
- num Subjects
- 6
- group Id
- FG005
- num Subjects
- 34
- group Id
- FG006
- num Subjects
- 5
- group Id
- FG007
- num Subjects
- 37
- type
- STARTED
- achievements
- group Id
- FG000
- num Subjects
- 310
- group Id
- FG001
- num Subjects
- 311
- group Id
- FG002
- num Subjects
- 27
- group Id
- FG003
- num Subjects
- 26
- group Id
- FG004
- num Subjects
- 0
- group Id
- FG005
- num Subjects
- 0
- group Id
- FG006
- num Subjects
- 0
- group Id
- FG007
- num Subjects
- 0
- type
- Randomized to Chemo
- achievements
- group Id
- FG000
- num Subjects
- 6
- group Id
- FG001
- num Subjects
- 145
- group Id
- FG002
- num Subjects
- 6
- group Id
- FG003
- num Subjects
- 139
- group Id
- FG004
- num Subjects
- 6
- group Id
- FG005
- num Subjects
- 34
- group Id
- FG006
- num Subjects
- 5
- group Id
- FG007
- num Subjects
- 37
- type
- Pre-specified Chemo
- achievements
- group Id
- FG000
- num Subjects
- 307
- group Id
- FG001
- num Subjects
- 433
- group Id
- FG002
- num Subjects
- 30
- group Id
- FG003
- num Subjects
- 129
- group Id
- FG004
- num Subjects
- 6
- group Id
- FG005
- num Subjects
- 31
- group Id
- FG006
- num Subjects
- 5
- group Id
- FG007
- num Subjects
- 34
- type
- COMPLETED
- achievements
- group Id
- FG000
- num Subjects
- 9
- group Id
- FG001
- num Subjects
- 23
- group Id
- FG002
- num Subjects
- 3
- group Id
- FG003
- num Subjects
- 36
- group Id
- FG004
- num Subjects
- 0
- group Id
- FG005
- num Subjects
- 3
- group Id
- FG006
- num Subjects
- 0
- group Id
- FG007
- num Subjects
- 3
- type
- NOT COMPLETED
- title
- Chemotherapy Assignment
- recruitment Details
- At the beginning of the study participants could be randomized to chemotherapy. On August 29, 2011 randomization to chemotherapy ended and participants could only be randomized to surgery.
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Not medical advice
Triangle